Madhya Pradesh toddler loses vision after doctor administers drops, probe underway

A 19-month-old child has lost his vision, with his family accusing a doctor at a civil hospital in Madhya Pradesh’s Sagar district of administering saline nasal drops into his eyes during treatment.

A 19-month-old child has lost his vision after undergoing treatment at a civil hospital in Madhya Pradesh’s Sagar district, with his family accusing a doctor of administering saline nasal drops into his eyes.

The incident took place on May 29, when Indraj Vishwakarma took his son, Vinay Vishwakarma, to the Civil Hospital in Banda after the child developed cold symptoms and redness in the eyes.

According to the complaint filed by the father, the on-duty government doctor examined the child and administered saline nasal drops into his eyes during treatment. The doctor also prescribed other medicines, including paracetamol syrup, an injection and additional medication, the family claimed.

The child’s condition worsened within a few hours, according to the complaint.

The family said they remained at the hospital for several hours, but seeing no improvement, doctors referred the child to the district hospital in Sagar. He was later advised advanced treatment at a higher medical facility.

Vinay was subsequently taken to AIIMS Bhopal for specialised treatment.

According to the complaint, doctors at AIIMS informed the family that the child had permanently lost vision. The father has claimed that doctors indicated the loss of eyesight could be linked to incorrect treatment or medical negligence.

Following the incident, Indraj Vishwakarma lodged a complaint at Banda police station, demanding action against the doctor and other hospital staff involved in the treatment.

He told police that while he did not know the doctor’s name, he could identify him.

The allegations have prompted an official inquiry.

Block Medical Officer Yogendra Khatik said the Chief Medical and Health Officer (CMHO) has constituted a committee to investigate the matter.

“The matter is being investigated by a committee constituted by the CMHO. Further action will be taken based on the findings of the probe,” Khatik said.

Authorities have not yet issued a detailed response to the family’s allegations regarding the treatment administered to the child.

The family has demanded a fair and impartial investigation and strict punishment for those found responsible.

The findings of the inquiry are expected to determine whether any medical negligence occurred and whether action will be taken against the doctor and hospital staff involved in the case.

Related Posts

CDSCO Mandates SUGAM Portal for Post-Approval Changes (PAC) to Vaccine and Anti-Sera Import Licences

New Delhi: The Central Drugs Standard Control Organization (CDSCO) has issued a critical regulatory directive aimed at completely digitizing and streamlining the import and registration protocols for biological products in India.…

WHO seeks details from India over oxytocin-linked deaths; licences of manufacturer cancelled

The World Health Organisation (WHO) has sought details from the Indian government following reports linking oxytocin injection manufactured by Jackson Laboratories to maternal deaths case in Rajasthan, even as the Centre clarified…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madhya Pradesh toddler loses vision after doctor administers drops, probe underway

Madhya Pradesh toddler loses vision after doctor administers drops, probe underway

CDSCO Mandates SUGAM Portal for Post-Approval Changes (PAC) to Vaccine and Anti-Sera Import Licences

CDSCO Mandates SUGAM Portal for Post-Approval Changes (PAC) to Vaccine and Anti-Sera Import Licences

WHO seeks details from India over oxytocin-linked deaths; licences of manufacturer cancelled

WHO seeks details from India over oxytocin-linked deaths; licences of manufacturer cancelled

DDA seizes suspected counterfeit asthma medicine in nationwide crackdown

DDA seizes suspected counterfeit asthma medicine in nationwide crackdown

HP HC quashes CDSCO complaints against pharma firms over jurisdictional and procedural lapses

HP HC quashes CDSCO complaints against pharma firms over jurisdictional and procedural lapses

Eli Lilly launches cancer drug Tanstrive in India

Eli Lilly launches cancer drug Tanstrive in India